Open Access
15 years with cuban rHuEPOs. Benefit and challenge
Jorge F Pérez-Oliva Díaz
- Vol. 12, Iss: 3, pp 464-471
Reads0
Chats0
TLDR
In this período, se ha prolongado la vida a millones de personas and ha permitido a otros cientos de miles el acceder a trasplante renal exitoso as mentioned in this paper.Abstract:
INTRODUCCIÓN Han transcurrido 50 años de la apertura de una nueva etapa para la Medicina contemporánea: la posibilidad de mantener con vida a pacientes con una falla renal terminal. En este período, se ha prolongado la vida a millones de personas y ha permitido a otros cientos de miles el acceder a un trasplante renal exitoso. La enfermedad renal crónica (ERC) se ha transformado en un problema de salud pública, al no tener límites éticos la aceptación de pacientes en hemodiálisisread more
Citations
More filters
Journal Article
PEER REVIEWED: Chronic Kidney Disease: A Public Health Problem That Needs a Public Health Action Plan
Anton C. Schoolwerth,Michael M. Engelgau,Kathy H Rufo,Frank Vinicor,Thomas H. Hostetter,Dolph Chianchiano,William M. McClellan,David G. Warnock +7 more
TL;DR: A broad and coordinated public health approach will be necessary to meet the burgeoning health, economic, and societal challenges of chronic kidney disease.
Journal ArticleDOI
New congress: New challenges for dialysis providers
References
More filters
Journal ArticleDOI
Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999
Robert N. Foley,Anne M. Murray,Shuling Li,Charles A. Herzog,A. Marshall McBean,Paul W. Eggers,Allan J. Collins +6 more
TL;DR: On a relative basis, patients with CKD were at a much greater risk for the least frequent study outcome, renal replacement therapy, than on an absolute basis, however, the high death rates of patientsWith CKD may reflect accelerated rates of atherosclerotic vascular disease and congestive heart failure.
Journal ArticleDOI
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis
TL;DR: To target higher haemoglobin concentrations when treating patients with anaemia caused by chronic kidney disease with recombinant human erythropoietin puts such patients at increased risk of death, according to current guidelines.
Journal ArticleDOI
Double-Blind Comparison of Full and Partial Anemia Correction in Incident Hemodialysis Patients without Symptomatic Heart Disease
Patrick S. Parfrey,Robert N. Foley,Barbara H. Wittreich,Daniel J. Sullivan,Martin J. Zagari,Dieter Frei +5 more
TL;DR: Overall adverse event rates were similar in both target groups; higher rates of skeletal pain, surgery, and dizziness were seen in the lower target group, and headache and cerebrovascular events wereseen in the higher target group.
Journal ArticleDOI
Effects of Short Daily versus Conventional Hemodialysis on Left Ventricular Hypertrophy and Inflammatory Markers: A Prospective, Controlled Study
TL;DR: Short daily hemodialysis is associated with improved fluid and phosphorus management and a reduction in LVH and inflammatory factors compared with conventional he modialysis.
Journal ArticleDOI
The Incidence of End-Stage Renal Disease Is Increasing Faster than the Prevalence of Chronic Renal Insufficiency
TL;DR: It is hypothesized that actual growth in kidney disease is only a minor contribution to the ongoing ESRD epidemic in the United States and tested this hypothesis by examining the change in population prevalence of kidney disease over 13 years relative to parallel changes in the incidence of E SRD.